Compared to HIF1A, data on the function of HIF2A in the tumor immune escape mechanism remain limited to date, and it has yet to be determined whether HIF2A may also be an upstream target to act on PD-L1/PD-1. The gene discussed is HIF1A; the disease is neoplasm.